Publication | Closed Access
The necessity of automated manufacture for cell-based immunotherapies: a cost-based analysis
16
Citations
0
References
2020
Year
VaccinationCell TherapyCost-based AnalysisMedicineImmunologyVaccine TrialCell-based ImmunotherapiesAutomated ManufactureTherapeutic VaccineImmunomodulationImmunotherapeuticsImmunotherapyCell EngineeringCell TransplantationSynthetic Immunology
No additional data available for this publication yet. Check back later!